• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: August 2018

Finance

Carbiotix closes pre-seed financing round

August 31, 2018 Microbiome Times

Carbiotix, an award winning biotechnology start-up focused on optimizing gut health with soluble fiber (prebiotics), has closed a second pre-seed financing round of 450,000 Euros, bringing the total capital raised to date to 700,000 Euros. Participating in […]

Pharma & Human Health

Clalit Health Services & DayTwo Join Forces to Bring to Market Glycemic-Control Product Based on the Gut Microbiome

August 29, 2018 Microbiome Times

Clalit Health Services, the leading HMO in Israel, and DayTwo are partnering to bring to market a glycemic-control product for people with Type 2 diabetes. The glycemic-control offering is based on the genetic sequencing of […]

Pharma & Human Health

4D Announces Publication of Data Highlighting Ability of MRx0004 to Protect Against Airway Inflammation in Severe Asthma

August 23, 2018 Microbiome Times

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, announces the publication of a paper demonstrating that MRx0004, a live biotherapeutic derived from the human gut microbiome, can protect against […]

Finance

Kaleido Biosciences Announces Appointment of Alison Lawton as Chief Executive Officer

August 22, 2018 Microbiome Times

Kaleido Biosciences, a clinical-stage healthcare company leading the development of novel chemistries that drive functions of the microbiome organ, today announced that Alison Lawton, Kaleido’s president and chief operating officer (COO), has been appointed to […]

Pharma & Human Health

BioCollective CEO Wins Science & Innovation Award for Collaborative Microbiome Scientific Discovery Platform

August 21, 2018 Microbiome Times

Nutrition Business Journal (NBJ) recently recognized the industry leadership of The BioCollective co-founder and CEO Martha Carlin by awarding her their annual prize for Science & Innovation.   A recent NBJ feature article on Carlin […]

Editor's Choice

Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing science and regulation of live microbiome-based products

August 20, 2018 Microbiome Times

Over the last several years, there’s been growing scientific and public interest in the role of microorganisms in the maintenance of overall health and prevention and treatment of disease. Today, more so than ever before, […]

Pharma & Human Health

Microbial Activity in the Mouth May Differentiate Children with Autism Spectrum Disorder

August 20, 2018 Microbiome Times

New research suggests that shifts in the bacteria within a child’s mouth could provide objective biomarkers for identifying autism spectrum disorder. The findings of this research, conducted by scientists from Penn State Medical Center, SUNY […]

Pharma & Human Health

The Microbiome Therapeutics Innovation Group Announces Coalition Formation and Leadership Team

August 16, 2018 Microbiome Times

The Microbiome Therapeutics Innovation Group (MTIG) announced the formation of their coalition which seeks to nurture innovation in microbiome therapeutics and microbiome-based products to address unmet medical needs and bring life-saving treatments to patients. The […]

Pharma & Human Health

Synlogic Publishes Preclinical Data Supporting Development of SYNB1618, a Synthetic Biotic™ Medicine as a Potential Treatment for Phenylketonuria

August 16, 2018 Microbiome Times

Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, announced the publication of data from preclinical studies of SYNB1618, the Company’s Synthetic Biotic development program targeting PKU, […]

Phytobiome & Environment

Pivot Bio Advances Toward Commercial Launch of First Sustainable Nitrogen Product

August 8, 2018 Microbiome Times

Across the Corn Belt this summer, Pivot Bio and farmers in the company’s Intent to Pivot program are beta testing the first sustainable source of nitrogen for corn. These plants receive nitrogen on-demand each day […]

Animal Health

THE ROLE OF BIOFILMS: An Interview with Scioto Biosciences

August 3, 2018 Microbiome Times

Our focus turns to biofilms and with the expertise of Scioto Biosciences, a preclinical stage company devoted to having a transformative impact on the delivery of microbiome therapeutics; we discuss their role, characteristics and future potential […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
  • Proven Complementary Effect of Probiotic Yeast and Bacteria
    June 21, 2023
  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
sign up

Sign up to the Microbiome Times newsletter